COVID-19: What Clinicians Serving Patients in Rural and Underserved Communities Need to Know
This program has expired.
Jointly provided by RME Collaborative and Postgraduate Institute for Medicine.
Release date: April 13, 2020
Expiration date: April 13, 2021
Estimated time to complete: 30 minutes
The novel coronavirus, COVID-19, is a public health emergency. Primary care clinicians in rural and underserved areas need the latest information available to help prepare them for the ongoing crisis. Since resources in such communities may be limited and numerous barriers to care exist, management of the virus may be particularly challenging. In this activity, expert faculty will share updates and perspectives on what healthcare professionals serving this population need to know today to safely and effectively care for patients with COVID-19. Current guidance on screening, testing, transmission, and potential therapies will also be reviewed.
Please note that any data, information, and guidance presented in the activity are current as of the recording on April 7, 2020 and are subject to change.
Paul E. Sax, MD (Activity Chair)
Clinical Director, Division of Infectious Diseases
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical School
Barbara P. Yawn, MD, MSc, MPH (Moderator)
Chief Science Officer, COPD Foundation
Professor of Family and Community Health
University of Minnesota
This activity is designed specifically for primary care clinicians and registered nurses who care for patients who reside in rural and underserved areas.
Upon completion of this activity, participants should be better able to:
- Review the evolving epidemiology of the coronavirus
- Describe the clinical presentation and diagnosis of coronavirus
- Utilize best practices for preventing the spread of coronavirus
- Review investigational therapies for coronavirus treatment
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and RME Collaborative. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CONTINUING MEDICAL EDUCATION
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CONTINUING NURSING EDUCATION
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hour. Designated for 0.1 contact hour of pharmacotherapy credit for Advanced Practice Registered Nurses.
How to Obtain Credit
If you wish to receive CME/CE credit, please follow the below steps:
- Listen to the entire activity.
- Go to www.cmeuniversity.com. In the “Find Post-Test/Evaluation by Course” field at the top of the page, enter the course code 15320.
- Complete the program evaluation form. A certificate of participation will be available to download/print immediately.
Disclosures of Conflicts of Interest
The Postgraduate Institute for Medicine requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Paul E. Sax, MD, has no financial disclosures to report.
Barbara P. Yawn, MD, MSc, MPH, has no financial disclosures to report.
Planners and Managers
The RME Collaborative and PIM planners and managers have nothing to disclose.
No commercial support was received for this activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
For questions regarding this CME/CE activity, please contact: RME Collaborative by phone, 800-913-9370 or email, email@example.com.
For questions about the accreditation of this activity, please visit www.pimed.com.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Computer System Requirements
- Operating system: Windows or Macintosh
- Supported browsers: HTML5-capable browser – Internet Explorer 11, Microsoft Edge, Firefox 27+, Chrome 30+, Safari 9+
- Hardware: computer, smartphone, or tablet
- Broadband Internet connection: high-speed connection preferable
©RME Collaborative, a division of Talem Health, LLC 2020. All Rights Reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Talem Health, LLC is prohibited.